Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Apollomics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
APLM
Nasdaq
2834
www.apollomicsinc.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Apollomics, Inc.
Apollomics Reports First-Half 2026 Financial Results
- Nov 9th, 2026 2:05 pm
Apollomics Announces $10 Million Private Placement Transaction
- Aug 11th, 2026 2:35 pm
Apollomics Regains Full Compliance with Nasdaq Listing Requirements
- Jul 13th, 2026 6:00 am
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
- Jun 24th, 2026 2:15 pm
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
- Apr 27th, 2026 6:00 am
Apollomics Inc. Announces $2.0 Million Bridge Financing
- Apr 1st, 2026 5:00 am
Apollomics Reports First Half 2025 Financial Results
- Dec 22nd, 2025 2:05 pm
Scroll